4
Changes in Ownership
Maze Therapeutics, Inc. Filed Acc 0001415889-25-002957
Director acquired 307,956 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lim Jonathan E Director | 2025-02-03 | Conversion | +37,724 | 37,724 | I: show line 1 in the form | ||
| Lim Jonathan E Director | 2025-02-03 | Conversion | +270,232 | 307,956 | I: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lim Jonathan E Director | 2025-02-03 | Conversion · Series A Preferred Stock | −363,703 | 0 | I: show line 3 in the form | |||||
| Lim Jonathan E Director | 2025-02-03 | Conversion · Series B Preferred Stock | −2,231,381 | 0 | I: show line 4 in the form | |||||
| Lim Jonathan E Director | 2024-12-09 | Grant or award · Stock Option (Right to Buy) | +5,704 | 5,704 | D: show line 5 in the form | |||||
| Lim Jonathan E Director | 2024-12-09 | Returned to the company · Stock Option (Right to Buy) | −5,704 | 0 | D: show line 6 in the form | |||||
| Lim Jonathan E Director | 2024-12-09 | Grant or award · Stock Option (Right to Buy) | +9,086 | 9,086 | D: show line 7 in the form |
Loading xslF345X05/form4-02042025_090248.xml…